Stockreport

GoodRx Holdings Inc (GDRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]

GoodRx Holdings, Inc. - Class A  (GDRX) 
PDF Full Year Adjusted EBITDA (2024): $260.2 million, up 20% year-over-year Prescription Transactions Revenue (2024): $577.5 million, up 5% year-over-year Subscription [Read more]